Platelet News and Research

RSS

Protein on the surface of platelets plays a key role in cancer-induced platelet aggregation

Scientists have provided new details about how cancer cells spread by surrounding themselves with platelets – the blood cells needed for blood clotting.

30 Aug 2007

Sex steroids, platelet aggregation and inflammation

In women, hormone therapy is a risk factor for venous thrombosis, a blood clot forming deep inside the vein. Despite the fact that the disorder is rare, it increases exponentially during menopause and can be deadly.

11 Aug 2007

New approach to assessing clot risk in menopausal women

In women, hormone therapy is a risk factor for venous thrombosis, a blood clot forming deep inside the vein.

9 Aug 2007

Efalizumab effective in treatment of heavy psoriasis

A meta-analysis of four randomized Phase III placebo-controlled trials confirms that the injectable drug Efalizumab, a humanized therapeutic antibody designed to selectively and reversibly block the activation, reactivation and trafficking of T-cells that lead to the development of psoriasis, had an acceptable safety and efficacy profile in the treatment of psoriasis in heavy patients, researchers at Mount Sinai School of Medicine announced today.

3 Aug 2007

Jump in cancer-related clots

Blood clots are increasingly common in cancer patients, but University of Rochester Medical Center researchers have created a novel risk model that can predict, with 98 percent certainty, which patients will not get a blood clot.

3 Aug 2007

New point of attack for future liver cancer treatments

The linking of two signalling pathways in the cells of liver tumours has a clear influence on their malignancy.

1 Aug 2007

Good signal for liver tumour therapy

The linking of two signalling pathways in the cells of liver tumours has a clear influence on their malignancy. Activation of the platelet-derived growth factor (PDGF) messenger molecule is decisive for this linking.

30 Jul 2007

Stroke in nonvascular atrial fibrillation

People with atrial fibrillation (AF) have irregular heart beats and have a tendency to form blood clots in the upper chambers (atria) of their hearts.

18 Jul 2007

New advance in search for effective treatment for human liver cancer

Researchers from the University of Pittsburgh School of Medicine report a significant new advance in the search for an effective treatment for human liver cancer in the July issue of Molecular Cancer Therapeutics.

12 Jul 2007

Obese heart attack patients more likely to survive after treatment than normal weight patients

Obese and very obese patients have a lower risk of dying after they have been treated for heart attacks than do normal weight patients, according to research published in the European Heart Journal today (Wednesday 20 June).

20 Jun 2007

Aspirin resistance

Aspirin is used by millions of patients for the prevention and treatment of coronary artery disease, the single leading cause of death in the world.

17 Jun 2007

Results of phase II studies of pazopanib

GlaxoSmithKline (GSK) has announced results from ongoing Phase II studies of pazopanib in advanced or metastatic renal cell carcinoma (RCC) and ovarian cancer.

5 Jun 2007

FDA approves Torisel (temsirolimus) for advanced kidney cancer

The U.S. Food and Drug Administration (FDA) hasapproved Torisel (temsirolimus) for the treatment of a certain type of advanced kidney cancer known as renal cell carcinoma.

1 Jun 2007

Gel made from platelets may help promote wound healing

A preliminary study suggests that topical application of a gel made from platelets in healthy individuals? own blood may help wounds heal more quickly and completely, according to a report in the May/June issue of Archives of Facial Plastic Surgery, one of the JAMA/Archives journals.

22 May 2007

Aspirin during pregnancy could reduce risk of pre-eclampsia

Women who receive aspirin or other antiplatelet drugs during pregnancy are at lower risk of pre-eclampsia, conclude authors of an article published in an upcoming edition of The Lancet.

20 May 2007

High-dose clopidogrel before stenting cuts heart attack risk in half

Pretreatment with double-dose anticlotting medication just before percutaneous coronary intervention (PCI) cuts the combined risk of heart attack and cardiac death by half, according to a study reported at the 30th Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI), May 9-12, 2007, in Orlando, FL.

15 May 2007